China · Biotechnology startup
China · Avistone Pharmaceuticals
Avistone Pharmaceuticals is a clinical-stage biotechnology company focused on precision oncology therapeutics.
Funding reportedLast round: Series B
Follow Avistone Pharmaceuticals and see its new rounds in your feed. Start following
What company datasets say Avistone Pharmaceuticals raised
Funding, as reported
Reported in all340.7Min the source's currency
Rounds2
Last roundSeries B
Last round dateDec 2023
Investors listed7
Biotechnology in China
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Avistone Pharmaceuticals in front of investors. Or tell us what we have wrong.